1. Home
  2. CYTK vs IDA Comparison

CYTK vs IDA Comparison

Compare CYTK & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.41

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo IDACORP Inc.

IDA

IDACORP Inc.

HOLD

Current Price

$128.14

Market Cap

6.8B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
IDA
Founded
1997
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
IDA
Price
$62.41
$128.14
Analyst Decision
Strong Buy
Buy
Analyst Count
16
7
Target Price
$82.38
$135.43
AVG Volume (30 Days)
2.2M
410.2K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
2.75%
EPS Growth
N/A
7.17
EPS
N/A
5.84
Revenue
$87,211,000.00
$1,805,885,000.00
Revenue This Year
$346.43
$6.64
Revenue Next Year
$57.69
$8.06
P/E Ratio
N/A
$21.94
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$104.74
52 Week High
$70.98
$138.03

Technical Indicators

Market Signals
Indicator
CYTK
IDA
Relative Strength Index (RSI) 49.43 52.11
Support Level $62.05 $124.81
Resistance Level $66.59 $129.59
Average True Range (ATR) 2.97 1.94
MACD 0.09 0.21
Stochastic Oscillator 33.47 67.01

Price Performance

Historical Comparison
CYTK
IDA

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

Share on Social Networks: